XML 72 R47.htm IDEA: XBRL DOCUMENT v3.23.1
SCHEDULE OF NET DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 13,200,000 $ 11,100,000
Stock-based compensation 13,810,000 10,500,000
Research and development costs 655,000
Research & development tax credits 330,000 358,000
Total deferred tax assets 27,995,000 21,958,000
Depreciation (106,000)
Intangible assets (113,000) (4,000)
Total deferred tax liabilities (219,000) (4,000)
Net deferred tax assets 27,776,000 21,954,000
Valuation allowance (27,776,000) (21,954,000)
Deferred tax asset, net of valuation allowance
Change in valuation allowance $ (5,822,000) $ (7,856,000)